Induced pluripotent stem cell lines derived from human somatic cells

Junying Yu, Maxim A. Vodyanik, Kim Smuga-Otto, Jessica Antosiewicz-Bourget, Jennifer L. Frane, Shulan Tian, Jeff Nie, Gudrun A. Jonsdottir, Victor Ruotti, Ron Stewart, Igor I. Slukvin, James A. Thomson

Research output: Contribution to journalArticlepeer-review

Abstract

Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state. We show that four factors (OCT4, SOX2, NANOG, and LIN28) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells. These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivatives of all three primary germ layers. Such induced pluripotent human cell lines should be useful in the production of new disease models and in drug development, as well as for applications in transplantation medicine, once technical limitations (for example, mutation through viral integration) are eliminated.

Original languageEnglish (US)
Pages (from-to)1917-1920
Number of pages4
JournalScience
Volume318
Issue number5858
DOIs
StatePublished - Dec 21 2007

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Induced pluripotent stem cell lines derived from human somatic cells'. Together they form a unique fingerprint.

Cite this